ConductScience.org, home

Paper37569710

A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model.

Mas A and 6 others. Int J Mol Sci, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model. Papers, record 37569710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37569710

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2023-08-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mas AAliciahttps://orcid.org/0000-0001-8947-3207
2Hurtado-Morillas CClara
3Martínez-Rodrigo AAbelhttps://orcid.org/0000-0003-3405-7171
4Orden JAJosé Ahttps://orcid.org/0000-0001-6352-1426
5de la Fuente RRicardo
6Domínguez-Bernal GGustavohttps://orcid.org/0000-0002-7693-653X
7Carrión JJavierhttps://orcid.org/0000-0001-7486-4942

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Vaccines, DNAMajor topic
LeishmaniasisMajor topic
Leishmaniasis VaccinesMajor topic
Leishmania infantumMajor topic
Leishmaniasis, VisceralMajor topic
Animals
Mice
Disease Models, Animal
Vaccination
DNA
Mice, Inbred BALB C
Antigens, Protozoan

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PID2019-106487RB-I00/AEI/10.13039/501100011033Government of SpainPubMed
S2018/BAA-4370Comunidad de MadridPubMed

Source PubMed

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123916336Three Leishmania/L. species--L. infantum, L. major, L. tropica--as causative agents of mucosal leishmaniasis in Iran.Pathog Glob Health2013https://conductscience.org/library/papers/23916336PubMed
233824489Emerging concepts in the science of vaccine adjuvants.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33824489PubMed
328915996Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells.Comp Immunol Microbiol Infect Dis2017https://conductscience.org/library/papers/28915996PubMed
436365010Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs.Pathogens2022https://conductscience.org/library/papers/36365010PubMed
531635276Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments.Vaccines (Basel)2019https://conductscience.org/library/papers/31635276PubMed
634428435Advancement in leishmaniasis diagnosis and therapeutics: An update.Eur J Pharmacol2021https://conductscience.org/library/papers/34428435PubMed
726895806Visceral leishmaniasis: a forgotten epidemic.Arch Dis Child2016https://conductscience.org/library/papers/26895806PubMed
829163510The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.Front Immunol2017https://conductscience.org/library/papers/29163510PubMed
928192528CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.PLoS Pathog2017https://conductscience.org/library/papers/28192528PubMed
1036336425Leishmaniasis.Vet Clin North Am Small Anim Pract2022https://conductscience.org/library/papers/36336425PubMed
1122693548Leishmaniasis worldwide and global estimates of its incidence.PLoS One2012https://conductscience.org/library/papers/22693548PubMed
1227615509Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte.Immunobiology2017https://conductscience.org/library/papers/27615509PubMed
1327424773Cutaneous leishmaniasis: immune responses in protection and pathogenesis.Nat Rev Immunol2016https://conductscience.org/library/papers/27424773PubMed
1426590047Impairment of Interleukin-17A Expression in Canine Visceral Leishmaniosis is Correlated with Reduced Interferon-γ and Inducible Nitric Oxide Synthase Expression.J Comp Pathol2015https://conductscience.org/library/papers/26590047PubMed
1529441060Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Front Immunol2018https://conductscience.org/library/papers/29441060PubMed
1631739549Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice.Vaccines (Basel)2019https://conductscience.org/library/papers/31739549PubMed
1731300103Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection.Comp Immunol Microbiol Infect Dis2019https://conductscience.org/library/papers/31300103PubMed
183598227Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.J Infect Dis1987https://conductscience.org/library/papers/3598227PubMed
1918040886L-arginine metabolism and its impact on host immunity against Leishmania infection.Immunol Res2008https://conductscience.org/library/papers/18040886PubMed
2026937644A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/26937644PubMed

See all 52 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41345965Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs.Vet Q2025https://conductscience.org/library/papers/41345965PubMed
41238927Genetic Manipulation Tools in Leishmania: From CRISPR/Cas9 to Vaccine Strategies for Disease Control.Acta Parasitol2025https://conductscience.org/library/papers/41238927PubMed
41183128Large-scale randomized double-blind field clinical trial for safety and efficacy assessment of the DNA vaccine Neoleish against canine leishmaniasis.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/41183128PubMed
38396573Enhancing Control of Leishmania infantum Infection: A Multi-Epitope Nanovaccine for Durable T-Cell Immunity.Animals (Basel)2024https://conductscience.org/library/papers/38396573PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37569710

GET https://conductscience.org/api/papers/v1/37569710/references?page=2